ZA982911B - Drug delivery system for two or more active substances - Google Patents

Drug delivery system for two or more active substances

Info

Publication number
ZA982911B
ZA982911B ZA982911A ZA982911A ZA982911B ZA 982911 B ZA982911 B ZA 982911B ZA 982911 A ZA982911 A ZA 982911A ZA 982911 A ZA982911 A ZA 982911A ZA 982911 B ZA982911 B ZA 982911B
Authority
ZA
South Africa
Prior art keywords
delivery system
drug delivery
active substances
substances
active
Prior art date
Application number
ZA982911A
Other languages
English (en)
Inventor
Rudolf Johannes Jo Groenewegen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA982911(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA982911B publication Critical patent/ZA982911B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA982911A 1997-04-11 1998-04-06 Drug delivery system for two or more active substances ZA982911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201098 1997-04-11

Publications (1)

Publication Number Publication Date
ZA982911B true ZA982911B (en) 1998-10-09

Family

ID=8228203

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982911A ZA982911B (en) 1997-04-11 1998-04-06 Drug delivery system for two or more active substances

Country Status (26)

Country Link
US (1) US5989581A (cs)
EP (1) EP0876815B1 (cs)
JP (2) JP4982670B2 (cs)
KR (1) KR100492676B1 (cs)
CN (1) CN1163222C (cs)
AR (1) AR011709A1 (cs)
AT (1) ATE211646T1 (cs)
AU (1) AU726934B2 (cs)
BR (1) BR9801027B1 (cs)
CA (1) CA2233753C (cs)
CZ (1) CZ294099B6 (cs)
DE (1) DE69803112T2 (cs)
DK (1) DK0876815T3 (cs)
ES (1) ES2171283T3 (cs)
HU (1) HU222343B1 (cs)
ID (1) ID21259A (cs)
IL (2) IL123813A0 (cs)
NO (1) NO320394B1 (cs)
NZ (1) NZ330145A (cs)
PL (1) PL192449B1 (cs)
PT (1) PT876815E (cs)
RU (1) RU2206325C2 (cs)
SG (1) SG65061A1 (cs)
TR (1) TR199800648A1 (cs)
TW (1) TW358031B (cs)
ZA (1) ZA982911B (cs)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US6039968A (en) † 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6361780B1 (en) * 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US7369463B1 (en) 2000-02-21 2008-05-06 N.V. Organon Electronic alarm timer for use with a medical regimen
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US7187980B2 (en) * 2001-11-09 2007-03-06 Oscor Inc. Cardiac lead with steroid eluting ring
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
WO2003094888A1 (en) * 2002-05-07 2003-11-20 Control Delivery Systems, Inc. Processes for forming a drug delivery device
MXPA05004929A (es) 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
AU2003298350A1 (en) * 2002-12-16 2004-07-09 Akzo Nobel N.V. Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device
US7357046B2 (en) * 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
JP4898431B2 (ja) * 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2005070950A1 (en) * 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
CN1906206A (zh) * 2004-01-15 2007-01-31 沃纳奇尔科特公司 雌二醇的二－甾族前体药物
BRPI0509146B8 (pt) * 2004-03-24 2021-05-25 Merck Sharp & Dohme sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
EP1814519A1 (en) * 2004-11-16 2007-08-08 Université de Liège Active substance delivery system comprising a hydrogel atrix and microcarriers
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
EP1898834A4 (en) * 2005-06-20 2010-12-15 Abbeymoor Medical Inc SELF-ADJUSTABLE ENDO-URETRAL DEVICE AND METHODS OF USE
TW200744610A (en) * 2005-06-21 2007-12-16 Organon Nv New regimens for controlled drug delivery devices for contraception
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
US7795241B2 (en) * 2005-07-12 2010-09-14 Warner Chilcott Company, Llc Derivative prodrugs of ethinyl estradiol
CA2610481A1 (en) * 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
CA2618349C (en) * 2005-08-11 2016-05-31 Massachusetts Institute Of Technology Intravesical drug delivery device and method
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
MX2009005446A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro vaginal para mirtazapina.
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
BRPI0820800B8 (pt) 2007-12-11 2021-06-22 Massachusetts Inst Technology dispositivo médico implantável para liberação controlada de droga
CA2733468C (en) * 2008-08-09 2017-12-05 Massachusetts Institute Of Technology Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
JP5632851B2 (ja) * 2008-11-07 2014-11-26 コンビネント・バイオメデイカル・システムズ・インコーポレーテツド 疾患を処置および／若しくは予防するための装置および方法
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
MX2011009679A (es) 2009-03-17 2011-09-30 Intervet Int Bv Dispositivo de suministro de farmaco zootecnico.
MX2011010607A (es) 2009-04-07 2012-04-02 Catholic Healthcare West Sistema y metodo de estimulacion electrica uterina.
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
CN104887388B (zh) 2009-06-03 2018-01-09 弗赛特影像5股份有限公司 前段药物输送
DK2445571T3 (da) 2009-06-26 2013-02-25 Taris Biomedical Inc Faste lægemiddeltabletter til implanterbare lægemiddelafgivelsesindretninger
CN102497855B (zh) 2009-07-21 2013-12-25 人口委员会股份有限公司 多层梯度的阴道环
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
RU2648827C2 (ru) * 2010-03-28 2018-03-28 Эвестра, Инк. Внутривлагалищное устройство для доставки лекарственного средства
EP2580191A2 (en) 2010-06-10 2013-04-17 The U.S.A. as represented by the Secretary, Department of Health and Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
CA2816073C (en) 2010-10-27 2018-12-18 Dignity Health Uterine electrical stimulation system and method
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
KR101263916B1 (ko) 2011-01-11 2013-05-13 이장희 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법
AU2012211960B2 (en) * 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
AU2012283837B2 (en) * 2011-07-20 2017-04-27 Patrick F. Kiser Intravaginal devices for drug delivery
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
CA2884030C (en) 2012-09-03 2018-04-10 Ecosea Farming S.A. Reservoir-cage submersion system for the culture and/or containment of hydrobiological species
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
EP2964088B1 (en) 2013-03-08 2023-05-10 Li Galli B.V. i.o. Vaginal drug delivery and/or diagnostic system
KR102398262B1 (ko) 2013-03-15 2022-05-13 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법
AU2014309012B2 (en) 2013-08-19 2019-03-14 Taris Biomedical Llc Multi-unit drug delivery devices and methods
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2016156403A1 (en) 2015-03-31 2016-10-06 Merck Sharp & Dohme B.V. Vaginal ring applicator
WO2016168141A1 (en) 2015-04-13 2016-10-20 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
EP3294300B1 (en) 2015-05-13 2024-12-18 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3395335A1 (en) 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
US11103460B2 (en) 2017-08-07 2021-08-31 Board Of Regents, The University Of Texas System Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
CN111971026A (zh) 2018-05-24 2020-11-20 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US20230404911A1 (en) * 2018-12-11 2023-12-21 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
MX2021006426A (es) * 2018-12-11 2021-09-14 Lupin Inc Sistema de suministro de farmaco para combinaciones de estrogeno de dosis ultra-baja y metodos y usos del mismo.
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
WO2021068239A1 (zh) 2019-10-12 2021-04-15 国家卫生健康委科学技术研究所 用于黄体支持的阴道缓释给药系统及其制备方法与应用
IL293335A (en) 2019-11-27 2022-07-01 Oak Crest Inst Of Science Sustained release drug delivery device
USD935018S1 (en) 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound
EP4448543A1 (en) 2022-01-06 2024-10-23 Oak Crest Institute of Science Subdermal implant for sustained drug delivery
EP4215181A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring
AU2023401287A1 (en) 2022-12-02 2025-06-19 Vari Bioscience Gmbh Estriol vaginal ring
WO2024220766A1 (en) 2023-04-19 2024-10-24 Oak Crest Institute Of Science Vaginal drug delivery device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
JPH03123727A (ja) * 1989-10-04 1991-05-27 Nitto Denko Corp 経皮吸収製剤
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
DE69433723T3 (de) * 1993-02-22 2008-10-30 Abraxis Bioscience, Inc., Los Angeles Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
DK0836473T3 (da) * 1995-07-04 2002-02-11 Akzo Nobel Nv Ringformede indretninger
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances

Also Published As

Publication number Publication date
BR9801027A (pt) 2000-01-11
NZ330145A (en) 1999-05-28
HU222343B1 (hu) 2003-06-28
AR011709A1 (es) 2000-08-30
PT876815E (pt) 2002-07-31
HK1016886A1 (en) 1999-11-12
NO320394B1 (no) 2005-11-28
CZ294099B6 (cs) 2004-10-13
IL123813A (en) 2001-11-25
CN1163222C (zh) 2004-08-25
AU6075198A (en) 1998-10-15
NO981638D0 (no) 1998-04-08
DE69803112D1 (de) 2002-02-14
BR9801027B1 (pt) 2009-01-13
ID21259A (id) 1999-05-12
CN1196930A (zh) 1998-10-28
JP2009256378A (ja) 2009-11-05
DK0876815T3 (da) 2002-04-22
CA2233753A1 (en) 1998-10-11
SG65061A1 (en) 1999-05-25
PL325774A1 (en) 1998-10-12
PL192449B1 (pl) 2006-10-31
AU726934B2 (en) 2000-11-23
RU2206325C2 (ru) 2003-06-20
CZ110298A3 (cs) 1998-10-14
IL123813A0 (en) 1998-10-30
TR199800648A1 (xx) 1998-10-21
EP0876815A1 (en) 1998-11-11
NO981638L (no) 1998-10-12
HU9800863D0 (en) 1998-05-28
CA2233753C (en) 2001-12-25
HUP9800863A3 (en) 2000-06-28
KR100492676B1 (ko) 2005-10-19
US5989581A (en) 1999-11-23
EP0876815B1 (en) 2002-01-09
KR19980081290A (ko) 1998-11-25
ES2171283T3 (es) 2002-09-01
JPH10287549A (ja) 1998-10-27
JP4982670B2 (ja) 2012-07-25
DE69803112T2 (de) 2002-07-18
ATE211646T1 (de) 2002-01-15
HUP9800863A2 (hu) 1999-02-01
TW358031B (en) 1999-05-11

Similar Documents

Publication Publication Date Title
PL325774A1 (en) Drug delivery system for two or more active substances
GB2338414B (en) Intravesical drug delivery system
HUP0001914A3 (en) Biocompatible compounds for pharmaceutical drug delivery systems
EP0981333A4 (en) INNOVATIVE SYSTEM FOR THE ADMINISTRATION OF ACTIVE MEDICINES BY AN ACOUSTIC PROCEDURE
AU7493398A (en) Pulsatile drug delivery system
ZA97405B (en) Gastrointestinal drug delivery system
AU6140598A (en) Multipathway electronically-controlled drug delivery system
ZA9710994B (en) Pharmaceutical formulations for sustained drug delivery
GB9818346D0 (en) Drug dispensing system
EP0989878A4 (en) DRUG DELIVERY SYSTEM
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
EG20670A (en) Active substance delivery system
AU7201998A (en) Drug delivery system
ZA97976B (en) Uniform drug delivery theraphy.
ZA983169B (en) Pharmaceutical dosage units
IL113793A (en) Transdermal delivery system comprising tiagabine for anti-epileptic drugs
EP1021137A4 (en) ARRANGEMENT FOR MEDICINE DELIVERY
GB9714750D0 (en) Drug delivery device
AU2420997A (en) Oligopeptides for drug delivery
AU1671997A (en) Drug delivery system using galactoxyloglucan
GB9404293D0 (en) Drug delivery system
GB9600471D0 (en) Drug delivery system
GB9700355D0 (en) Drug delivery system
AUPO820797A0 (en) Drug delivery system
GB9800835D0 (en) Drug delivery system